Under normal conditions, the body is protected against immune system-mediated self-destruction by marker proteins that indicate that host cells are ‘off limits’ and should be ignored. In patients with rheumatoid arthritis (RA), however, such safeguards fail to prevent immune cells from damaging joint tissues.
Although an estimated 1% of the world’s population is affected by RA, the roots of this disorder are poorly understood. Now, a multi-institutional team of Japanese researchers led by Yuta Kochi and Kazuhiko Yamamoto of the RIKEN Center for Genomic Medicine in Yokohama has characterized potential genetic risk factors1.
The researchers performed a large-scale ‘genome-wide association study’, screening thousands of Japanese individuals to identify small genomic sequence variations—so-called ‘single-nucleotide polymorphisms’ (SNPs)—that are linked with RA susceptibility to a statistically meaningful degree. The strongest association they identified was for a SNP in the vicinity of the gene encoding chemokine (C-C motif) receptor 6 (CCR6). Subsequent analysis of two large, independent cohorts of Japanese subjects provided further confirmation of the connection between this CCR6 SNP and RA.
The CCR6 receptor recognizes signals that stimulate immune cell development, and triggers immune system effects that could be directly relevant to RA. “This receptor has been shown to be important for the migration and recruitment of immune cells such as dendritic cells, T cells, and B-cells during inflammatory and immunological responses” says Kochi, “and it may also regulate the differentiation and maturation of these cells.” Closer examination by the researchers subsequently revealed a second potentially important genetic variation affecting CCR6 expression. They also determined that the elevated CCR6 activity resulting from this variation was strongly associated with RA.
CCR6 appears to exert its pathological effects by promoting the inflammatory response triggered by a recently identified class of helper T cells known as Th17 cells. “We believe the primary role of CCR6 in RA pathogenesis is facilitating the entry of Th17 cells into the joints,” says Kochi. “And as CCR6 is also involved in the migration and differentiation of B-cells, it could also influence the activity of auto-reactive B-cells.” Strikingly, these CCR6 variants also appear to contribute to two other inflammatory conditions, Graves’ disease and Crohn’s disease.
Following on from this discovery, Kochi and Yamamoto are hopeful that their data will yield additional candidate genes that enable further insights into how RA patients’ immune systems end up going off-course. “Many other genetic factors other than CCR6 remain to be discovered,” says Kochi.
The corresponding author for this highlight is based at the Laboratory for Autoimmune Diseases, RIKEN Center for Genomic Medicine
1. Kochi, Y., Okada, Y., Suzuki, A., Ikari, K., Terao, C., Takahashi, A., Yamazaki, K., Hosono, N., Myouzen, K., Tsunoda, T. et al. A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility. Nature Genetics 42, 515–519 (2010)
gro-pr | Research asia research news
Zebrafish's near 360 degree UV-vision knocks stripes off Google Street View
22.06.2018 | University of Sussex
New cellular pathway helps explain how inflammation leads to artery disease
22.06.2018 | Cedars-Sinai Medical Center
In a recent publication in the renowned journal Optica, scientists of Leibniz-Institute of Photonic Technology (Leibniz IPHT) in Jena showed that they can accurately control the optical properties of liquid-core fiber lasers and therefore their spectral band width by temperature and pressure tuning.
Already last year, the researchers provided experimental proof of a new dynamic of hybrid solitons– temporally and spectrally stationary light waves resulting...
Scientists from the University of Freiburg and the University of Basel identified a master regulator for bone regeneration. Prasad Shastri, Professor of...
Moving into its fourth decade, AchemAsia is setting out for new horizons: The International Expo and Innovation Forum for Sustainable Chemical Production will take place from 21-23 May 2019 in Shanghai, China. With an updated event profile, the eleventh edition focusses on topics that are especially relevant for the Chinese process industry, putting a strong emphasis on sustainability and innovation.
Founded in 1989 as a spin-off of ACHEMA to cater to the needs of China’s then developing industry, AchemAsia has since grown into a platform where the latest...
The BMBF-funded OWICELLS project was successfully completed with a final presentation at the BMW plant in Munich. The presentation demonstrated a Li-Fi communication with a mobile robot, while the robot carried out usual production processes (welding, moving and testing parts) in a 5x5m² production cell. The robust, optical wireless transmission is based on spatial diversity; in other words, data is sent and received simultaneously by several LEDs and several photodiodes. The system can transmit data at more than 100 Mbit/s and five milliseconds latency.
Modern production technologies in the automobile industry must become more flexible in order to fulfil individual customer requirements.
An international team of scientists has discovered a new way to transfer image information through multimodal fibers with almost no distortion - even if the fiber is bent. The results of the study, to which scientist from the Leibniz-Institute of Photonic Technology Jena (Leibniz IPHT) contributed, were published on 6thJune in the highly-cited journal Physical Review Letters.
Endoscopes allow doctors to see into a patient’s body like through a keyhole. Typically, the images are transmitted via a bundle of several hundreds of optical...
13.06.2018 | Event News
08.06.2018 | Event News
05.06.2018 | Event News
22.06.2018 | Materials Sciences
22.06.2018 | Earth Sciences
22.06.2018 | Life Sciences